Last Updated: November 13, 2026

Details for New Drug Application (NDA): 022090

NDA 022090 describes EOVIST, which is a drug marketed by Bayer Hlthcare and is included in one NDA. It is available from one supplier. Additional details are available on the EOVIST profile page.

The generic ingredient in EOVIST is gadoxetate disodium. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the gadoxetate disodium profile page.

Summary for 022090

Tradename:	EOVIST
Applicant:	Bayer Hlthcare
Ingredient:	gadoxetate disodium
Patents:	0

Pharmacology for NDA: 022090

Mechanism of Action	Magnetic Resonance Contrast Activity

Suppliers and Packaging for NDA: 022090

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
EOVIST	gadoxetate disodium	SOLUTION;INTRAVENOUS	022090	NDA	Bayer HealthCare Pharmaceuticals Inc.	50419-320	50419-320-05	5 VIAL, SINGLE-DOSE in 1 BOX (50419-320-05) / 10 mL in 1 VIAL, SINGLE-DOSE
EOVIST	gadoxetate disodium	SOLUTION;INTRAVENOUS	022090	NDA	Bayer HealthCare Pharmaceuticals Inc.	50419-320	50419-320-15	5 VIAL, SINGLE-DOSE in 1 BOX (50419-320-15) / 15 mL in 1 VIAL, SINGLE-DOSE

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	SOLUTION;INTRAVENOUS			Strength	1.8143GM/10ML (181.43MG/ML)
Approval Date:	Jul 3, 2008	TE:		RLD:	Yes

Profile for product number 002

Active Rx/OTC/Discontinued:	RX	Dosage:	SOLUTION;INTRAVENOUS			Strength	2.72145GM/15ML (181.43MG/ML)
Approval Date:	Feb 4, 2013	TE:		RLD:	Yes

Expired US Patents for NDA 022090

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Bayer Hlthcare	EOVIST	gadoxetate disodium	SOLUTION;INTRAVENOUS	022090-001	Jul 3, 2008	5,798,092	⤷ Start Trial
Bayer Hlthcare	EOVIST	gadoxetate disodium	SOLUTION;INTRAVENOUS	022090-002	Feb 4, 2013	6,039,931	⤷ Start Trial
Bayer Hlthcare	EOVIST	gadoxetate disodium	SOLUTION;INTRAVENOUS	022090-001	Jul 3, 2008	6,039,931	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.